REPORT ID 3243

Global Gastrointestinal Stromal Tumor (GIST) Drug Market Research Report 2017

Publish Date
13-Dec-17
Pages
114
Format
Electronic (PDF)

In this report, the global Gastrointestinal Stromal Tumor (GIST) Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Gastrointestinal Stromal Tumor (GIST) Drug in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Gastrointestinal Stromal Tumor (GIST) Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Ariad Pharmaceuticals, Inc.
    Arog Pharmaceuticals, Inc.
    Array BioPharma Inc.
    Astex Pharmaceuticals, Inc.
    Blueprint Medicines Corporation
    Boston Biomedical, Inc.
    Calithera Biosciences, Inc.
    Chipscreen Biosciences Ltd
    Deciphera Pharmaceuticals, LLC
    F. Hoffmann-La Roche Ltd.
    Horizon Pharma Plc
    Immunicum AB
    Jiangsu Hengrui Medicine Co., Ltd.
    Kolltan Pharmaceuticals, Inc.
    Natco Pharma Limited
    Nerviano Medical Sciences S.r.l.
    Novartis AG
    Omeros Corporation
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Amcasertib
    Anagrelide hydrochloride CR
    APG-1351
    Binimetinib
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Clinic
    Hospital
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Gastrointestinal Stromal Tumor (GIST) Drug Market Research Report 2017
1 Gastrointestinal Stromal Tumor (GIST) Drug Market Overview
    1.1 Product Overview and Scope of Gastrointestinal Stromal Tumor (GIST) Drug
    1.2 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type (Product Category)
        1.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Type (Product Category) in 2016
        1.2.3 Amcasertib
        1.2.4 Anagrelide hydrochloride CR
        1.2.5 APG-1351
        1.2.6 Binimetinib
        1.2.7 Others
    1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application
        1.3.1 Gastrointestinal Stromal Tumor (GIST) Drug Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Clinic
        1.3.3 Hospital
        1.3.4 Others
    1.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Market by Region (2012-2022)
        1.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Gastrointestinal Stromal Tumor (GIST) Drug (2012-2022)
        1.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Status and Outlook (2012-2022)
        1.5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production Status and Outlook (2012-2022)

2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Competition by Manufacturers
    2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Production and Share by Manufacturers (2012-2017)
    2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Gastrointestinal Stromal Tumor (GIST) Drug Market Competitive Situation and Trends
        2.5.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Concentration Rate
        2.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity and Market Share by Region (2012-2017)
    3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Production and Market Share by Region (2012-2017)
    3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Gastrointestinal Stromal Tumor (GIST) Drug Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Region (2012-2017)
    4.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export, Import (2012-2017)
    4.4 China Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export, Import (2012-2017)
    4.7 India Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption, Export, Import (2012-2017)

5 Global Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue (Value), Price Trend by Type
    5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production and Market Share by Type (2012-2017)
    5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Type (2012-2017)
    5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2012-2017)
    5.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Growth by Type (2012-2017)

6 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis by Application
    6.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption and Market Share by Application (2012-2017)
    6.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Profiles/Analysis
    7.1 Ariad Pharmaceuticals, Inc.
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Arog Pharmaceuticals, Inc.
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Array BioPharma Inc.
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Astex Pharmaceuticals, Inc.
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Blueprint Medicines Corporation
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Boston Biomedical, Inc.
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Calithera Biosciences, Inc.
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Chipscreen Biosciences Ltd
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Deciphera Pharmaceuticals, LLC
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 F. Hoffmann-La Roche Ltd.
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Gastrointestinal Stromal Tumor (GIST) Drug Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Horizon Pharma Plc
    7.12 Immunicum AB
    7.13 Jiangsu Hengrui Medicine Co., Ltd.
    7.14 Kolltan Pharmaceuticals, Inc.
    7.15 Natco Pharma Limited
    7.16 Nerviano Medical Sciences S.r.l.
    7.17 Novartis AG
    7.18 Omeros Corporation

8 Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Cost Analysis
    8.1 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Gastrointestinal Stromal Tumor (GIST) Drug Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Gastrointestinal Stromal Tumor (GIST) Drug Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Forecast (2017-2022)
    12.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Price and Trend Forecast (2017-2022)
    12.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary S